Stroke Management
The goal for the acute management / Stroke Management of patients with stroke is to stabilize the patient and to complete initial evaluation and assessment, including imaging and laboratory studies, within 60 minutes of patient arrival. Critical decisions focus on the need for intubation, blood pressure control, and determination of risk/benefit for thrombolytic intervention. General Management of Patients With Acute Stroke:
Blood glucose :Treat hypoglycemia with D50
Treat hyperglycemia with insulin if serum glucose >200 mg/dL
Blood pressure: For thrombolysis candidates and non candidates
Cardiac monitor: Continuous monitoring for ischemic changes or atrial fibrillation
Intravenous fluids: Avoid D5W and excessive fluid administration
IV isotonic sodium chloride solution at 50 mL/h unless otherwise indicated
Oral intake: NPO initially; aspiration risk is great, avoid oral intake until swallowing assessed
Oxygen: Supplement if indicated (Sa02< 94%)
Temperature: Avoid hyperthermia; use oral or rectal acetaminophen and cooling blankets as needed
- Thrombolytic Therapy
- Stabilization of Airway and Breathing
- Intravenous Access and Cardiac Monitoring
Related Conference of Stroke Management
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Stroke Management Conference Speakers
Recommended Sessions
- Brain Tumor and Neuro-oncology
- Alzheimers Disease
- Cannabis - Therapeutics and different Uses
- Cerebrovascular Disease
- Clinical Trials and Case Reports
- CNS Disorders
- Dementia and Mental Health
- Dementia and Mental Health
- Huntingtons infection
- Modern Diagnostics
- Neuro Oncology
- Neurodegenerative Disease
- Neurological Nursing
- Neuropharmacology
- Neurophysiology, Neuroimaging and Radiology
- Neuropsychiatry
- Parkinson Disease
- Psychological state
- Risk Assessment and Prevention of Stroke
- Seizure Disorder and Epilepsy
- Stroke
- Stroke Management
- Stroke Rehabilitation and Recovery
- Therapeutic Approaches
- Tourette Syndrome
Related Journals
Are you interested in
- 3D Bioprinting, Organ Fabrication & Bioartificial Tissues - Stem Cell 2026 (Netherlands)
- Aging Biology, Longevity Science & Cellular Rejuvenation - Stem Cell 2026 (Netherlands)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioinformatics, AI Models & Predictive Regeneration - Stem Cell 2026 (Netherlands)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells & Targeted Therapeutics - Stem Cell 2026 (Netherlands)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiac, Vascular & Musculoskeletal Regeneration - Stem Cell 2026 (Netherlands)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Translation of Stem Cell Therapies - Stem Cell 2026 (Netherlands)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Commercialization, Biobanking & Industry Innovations - Stem Cell 2026 (Netherlands)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Regulatory & Quality Control Frameworks - Stem Cell 2026 (Netherlands)
- Exosomes, Extracellular Vesicles & Cell-Free Therapeutics - Stem Cell 2026 (Netherlands)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Gene Editing, CRISPR Therapies & Regenerative Genomics - Stem Cell 2026 (Netherlands)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regeneration in Neurodegenerative & Spinal Cord Disorders - Stem Cell 2026 (Netherlands)
- Regenerative Approaches in Diabetes & Metabolic Disorders - Stem Cell 2026 (Netherlands)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Immunology & Immune Modulation - Stem Cell 2026 (Netherlands)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell Engineering & Cellular Reprogramming - Stem Cell 2026 (Netherlands)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
- Tissue Engineering, Biomaterials & Smart Scaffolds - Stem Cell 2026 (Netherlands)

